![Vitamin D Therapy Market, Size, Share, Growth - 2020-207](https://d1tlrxy0mfxnyo.cloudfront.net/thumbnail/343985/36b8cb9c-7021-46f1-8874-5535d625ef5d.png?width=649)
Market Overview
- The Global Vitamin D Therapy Market is expected to grow at a CAGR of 12.2% during the forecasting period (2020-2027).
- Vitamin D is a fat-soluble vitamin produced by the body in response to skin being exposed to sunlight. It also occurs naturally in a few foods such as some fish, fish liver oils, egg yolks, and fortified dairy and grain products. Vitamin D is essential for supporting calcium metabolism in the body. It helps the body absorb calcium from food and supplements to support the maintenance of healthy bone cells. Vitamin D also supports muscle health, plays a role in the immune system, aids cell growth regulates blood pressure, and supports cardiovascular health. People with serum vitamin D levels of less than 20 ng/mL are at risk for vitamin D deficiency. Serum levels below 12 ng/mL indicate there is a vitamin D deficiency. Vitamin D deficiency can cause diabetes, cancer, rickets, osteoporosis, and kidney diseases. According to vitamin D council, in 2017, approximately one billion individuals worldwide, or nearly 15% of the world’s population, are vitamin D deficient or insufficient.
Download free sample: https://www.datamintelligence.com/download-sample/vitamin-d-therapy-market
Market Dynamics
- The market growth is driven by factors such as growing awareness about vitamin D deficiency, a rise in the geriatric population, an imbalanced diet, obesity, and a sedentary lifestyle.
- People's ability to absorb vitamin D may decline with increasing age. According to the report by the United Nations (UN) population division, nearly 962 million people around the world are 60 years old or older, which represents 13% of the world population. This phenomenon has a growth rate of 3% annually, and according to estimates, by 2030 the number of elderly people will reach nearly 1400 million people. Furthermore, according to the World Health Organization (WHO), In 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these over 650 million were obese. Vitamin D is extracted from the blood by fat cells, altering its release into the circulation. People with a body mass index of 30 or higher often have low blood levels of vitamin D.
- Lack of awareness among the standard population and side effects associated with external intake of supplements can restrain the market growth over the forecast period.
Segmentation Analysis
- The global vitamin D therapy market can be segmented by route of administration as Oral, Parenteral, and Topical, by application as Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders, and Others and by distribution channel as Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
- By route of administration, the oral route is expected to account for the largest share of the market during the forecast period due to the ease of administration, easy availability, and reduced the chance of toxicity. Ergocalciferol (Vitamin D2), Cholecalciferol (Vitamin D3), Cholecalciferol (Vitamin D3) are the brand names that are available orally. The oral form does not require measurement precision as in the case of other ways.
- Based on the application, the osteoporosis segment is expected to register the highest CAGR during the period of forecast. Osteoporosis leads to low bone density. Bones are made of many minerals, but calcium is the most important. 99% of the calcium in the body is found in teeth and bones. Calcium makes bones dense and strong. The human body requires vitamin D to absorb the calcium present in the diet. When the body does not get enough vitamin D, it cannot absorb the calcium needed for the bones. According to the International Osteoporosis Foundation (IOF), worldwide, osteoporosis causes more than 8.9 million fractures annually, resulting in an osteoporotic fracture every three seconds.
Geographical Analysis
- Geographically, the global vitamin D therapy market is divided into North America, Europe, South America, Asia-Pacific, and the Middle East and Africa.
- North America is expected to account for the largest market share throughout forecast due to a rise in cases of vitamin D deficiency and other chronic diseases such as osteoporosis, public awareness, supportive government policies, and high reimbursement. According to IOF, osteoporosis and low bone mass are estimated to be a significant public health threat for almost 44 million U.S. women and men aged 50 and older.
- The Asia Pacific region is expected to register the highest CAGR during the forecast period due to rise in the target population, increasing awareness about vitamin D deficiency among common public and medical practitioners, implementation of programs for the awareness and treatment of vitamin D deficiency, heavy air pollution, and sedentary lifestyles.
Competitive Analysis
- Some of the primary key players in the market are Abbott, Sanofi, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories, Sun Pharmaceutical Industries, and Cadila Healthcare Ltd. In March 2018, GlaxoSmithKline plc formed an agreement with Novartis to acquire their full ownership of Consumer Healthcare Business with a 36.5% stake in the Consumer Healthcare Joint Venture for $13 billion.
Market Taxonomy
Based on the route of administration, the global vitamin D therapy market is segmented into:
- Oral
- Parenteral
- Topical
Based on application, the global vitamin D therapy market is segmented into:
- Osteoporosis
- Rickets
- Skin Diseases
- Muscle Weakness
- Autoimmune Disorders
- Others
Based on the distribution channel, the global vitamin D therapy market is segmented into:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Based on the region, the global vitamin D therapy market is segmented into:
- North America
- South America
- Europe
- Asia Pacific
- The Middle East and Africa
View full report: https://www.datamintelligence.com/research-report/vitamin-d-therapy-market
Enquiry before buying: https://www.datamintelligence.com/enquiry/vitamin-d-therapy-market
About Us
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at DataM Intelligence
Email: [email protected]
Tel: +1 877 441 4866
Website: www.datamintelligence.com